Stryker Corp (SYK)
215.85
+6.01 (+2.86%)
USD |
NYSE |
Oct 04, 16:00
215.80
-0.05 (-0.02%)
After-Hours: 17:04
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 81.66B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -20.82% |
| Valuation | |
| PE Ratio | 39.75 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 4.683 |
| Price to Book Value | 5.210 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.695 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.8537 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 43.80% |
News
Headline
Wire
Time (ET)
Yahoo
10/04 07:00
Yahoo
09/30 07:00
Yahoo
09/26 07:00
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 10/28/2022* | -- | Results | Q3 2022 | -- | 2.24 | -- | |
| 10/28/2022* | 16:30 EST | Earnings Call | Q3 2022 | -- | -- | -- | |
| 07/26/2022 | -- | Results | Q2 2022 | 2.25 | 2.28 | -1.51% | |
| 07/26/2022 | 16:30 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
| 04/28/2022 | -- | Results | Q1 2022 | 1.97 | 1.94 | 1.56% | |
| 04/28/2022 | 16:30 EST | Earnings Call | Q1 2022 | -- | -- | -- | |
| 01/27/2022 | 16:30 EST | Earnings Call | Q4 2021 | -- | -- | -- | |
| 01/27/2022 | -- | Results | Q4 2021 | 2.71 | 2.72 | -0.45% |
*Estimated Date/Time
Earnings
Profile
Edit
| Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Nearly one fourth of Stryker's total revenue currently comes from outside the United States. |
| URL | https://www.stryker.com |
| Investor Relations URL | https://investors.stryker.com |
| HQ State/Province | Michigan |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Oct. 28, 2022 (est.) |
| Last Earnings Release | Jul. 26, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 29, 2022 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 2.715 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.9019 |
| Yield to Sector | 0.7179 |
| Yield to Industry | 0.745 |
| Last Dividend Amt. | 0.695 |
| Dividend Frequency | Quarterly |
| Last Ex-Dividend Date | Sep. 29, 2022 |
| Yield (TTM) | 1.29% |
| Forward Yield | 1.32% |
| Payout Ratio | 48.10% |
| Cash Payout Ratio | 48.38% |
| Consistent Payer (5Y) |
|
| Consistent Growth (5Y) |
|
Risk Info
Total Returns Comparison
Annual Total Returns Versus Peers
As of October 03, 2022.
Fundamentals
| Revenue (TTM) | 17.63B |
| Total Expenses (TTM) | 14.98B |
| Net Income (TTM) | 2.079B |
| Total Assets (Quarterly) | 36.03B |
| Total Liabilities (Quarterly) | 20.36B |
| Shareholders Equity (Quarterly) | 15.67B |
| Cash from Operations (TTM) | 2.665B |
| Cash from Investing (TTM) | -3.395B |
| Cash from Financing (TTM) | -396.00M |
Ratings
Profile
Edit
| Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Nearly one fourth of Stryker's total revenue currently comes from outside the United States. |
| URL | https://www.stryker.com |
| Investor Relations URL | https://investors.stryker.com |
| HQ State/Province | Michigan |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Large Cap/Blend |
| Next Earnings Release | Oct. 28, 2022 (est.) |
| Last Earnings Release | Jul. 26, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 29, 2022 |
Risk Info
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Top Fund Holders
| Symbol | Dollars Invested | % Weight |
|---|---|---|
| HHL.TO | 52.96M USD | 4.86% |
| IHI | 275.76M USD | 4.67% |
| JENRX | 401.17M USD | 4.12% |
| FRDRX | 687.93M USD | 2.83% |
| VDIGX | 1.262B USD | 2.51% |
| VGHCX | 1.016B USD | 2.24% |
| IYH | 45.06M USD | 1.50% |
| XLV | 550.74M USD | 1.49% |
| FHLC | 36.09M USD | 1.28% |
| VHT | 237.12M USD | 1.28% |
| RRGSX | 449.06M USD | 0.96% |
| TRZBX | 490.50M USD | 0.78% |
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Morningstar | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| SYK Tweets |